Výsledky vyhledávání - Cecilie Blimark
- Zobrazuji výsledky 1 - 12 z 12
-
1
-
2
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study Autor Sigrún Þorsteinsdóttir, Paul W. Dickman, Ola Landgren, Cecilie Blimark, Malin Hultcrantz, Ingemar Turesson, Magnus Björkholm, Sigurður Y. Kristinsson
Vydáno 2018Carta -
3
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients Autor Cecilie Blimark, Erik Holmberg, Ulf‐Henrik Mellqvist, Ola Landgren, Magnus Björkholm, Malin Hultcrantz, Christian Kjellander, Ingemar Turesson, S. Y. Kristinsson
Vydáno 2014Artigo -
4
Patterns of hematologic malignancies and solid tumors among 37,838 first‐degree relatives of 13,896 patients with multiple myeloma in Sweden Autor Sigurður Y. Kristinsson, Magnus Björkholm, Lynn R. Goldin, Cecilie Blimark, Ulf‐Henrik Mellqvist, Anders Wåhlin, Ingemar Turesson, Ola Landgren
Vydáno 2009Artigo -
5
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study Autor Sigurður Y. Kristinsson, Min Tang, Ruth M. Pfeiffer, Magnus Björkholm, Cecilie Blimark, Ulf‐Henrik Mellqvist, Anders Wåhlin, Ingemar Turesson, Ola Landgren
Vydáno 2010Artigo -
6
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study Autor Ebba K. Lindqvist, Lynn R. Goldin, Ola Landgren, Cecilie Blimark, Ulf‐Henrik Mellqvist, Ingemar Turesson, Anders Wåhlin, Magnus Björkholm, Sigurður Y. Kristinsson
Vydáno 2011Artigo -
7
Risk of plasma cell and lymphoproliferative disorders among 14621 first-degree relatives of 4458 patients with monoclonal gammopathy of undetermined significance in Sweden Autor Ola Landgren, Sigurður Y. Kristinsson, Lynn R. Goldin, Neil E. Caporaso, Cecilie Blimark, Ulf‐Henrik Mellqvist, Anders Wåhlin, Magnus Björkholm, Ingemar Turesson
Vydáno 2009Artigo -
8
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study Autor Sigurður Y. Kristinsson, Ruth M. Pfeiffer, Magnus Björkholm, Lynn R. Goldin, Sam Schulman, Cecilie Blimark, Ulf‐Henrik Mellqvist, Anders Wåhlin, Ingemar Turesson, Ola Landgren
Vydáno 2010Artigo -
9
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study Autor Sigurður Y. Kristinsson, Min Tang, Ruth M. Pfeiffer, Magnus Björkholm, Lynn R. Goldin, Cecilie Blimark, Ulf Henrik Mellqvist, Anders Wåhlin, Ingemar Turesson, Ola Landgren
Vydáno 2011Artigo -
10
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study Autor Sigurður Y. Kristinsson, Magnus Björkholm, Therése Andersson, Sandra Eloranta, Paul W. Dickman, Lynn R. Goldin, Cecilie Blimark, Ulf‐Henrik Mellqvist, Anders Wåhlin, Ingela Turesson, Ola Landgren
Vydáno 2009Artigo -
11
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry Autor Cecilie Blimark, Ingemar Turesson, Anna Genell, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Karin Forsberg, Gunnar Juliusson, Olle Linder, Ulf‐Henrik Mellqvist, Hareth Nahi, Sigurður Y. Kristinsson
Vydáno 2017Artigo -
12
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial Autor Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlíf Steingrímsdóttir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie S. Dahl, Karin Forsberg, Tobias Gedde‐Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindås, Niels Frost Andersen, Ingemar Turesson, Anders Waage, Jan Westin
Vydáno 2013Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Multiple myeloma
Environmental health
Population
Immunology
Antibody
Monoclonal
Monoclonal antibody
Monoclonal gammopathy of undetermined significance
Confidence interval
Gastroenterology
Macroglobulinemia
Oncology
Family history
Hazard ratio
Bortezomib
First-degree relatives
Incidence (geometry)
Leukemia
Optics
Physics
Surgery
Asymptomatic
Autoimmune disease
Autologous stem-cell transplantation
Biology
Cancer
Case-control study
Cellulitis